DistressOther
DMK PHARMACEUTICALS Corp acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
DMK PHARMACEUTICALS Corp -> target
DMK believes that its library of approximately 750 small molecule neuropeptide analogues and differentiated pipeline can address significant unmet medical needs by integrating with the body's own efforts to regain balance of disrupted physiology.
Open source record (SEC) ↗